3YC-13843-51932
3 vaccinations
1 coded response
38 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 282 / NC
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-19
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-26
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-16
- 2021-04-21
- 2021-04-28
- 2021-05-07
- 2021-06-23
- 2021-09-22
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-05
- 2022-04-04
-
2022-10-05
Survey response — 12 months, dose 3MedDRA: Dizziness, Fatigue, Malaise, Muscle spasms, Weight increased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gallbladder cramping, weight gain, dizziness, fatigue, general unwell feelingMedDRA releases: 2024-11 · check-in free text available
-
2022-10-05
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-05 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: Gallbladder cramping, weight gain, dizziness, fatigue, general unwell feeling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Weight increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release